U.S. markets open in 8 hours 27 minutes

Neurocrine Biosciences, Inc. (NBIX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
94.60+2.67 (+2.90%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 5/13/2021
Current
3/31/202112/31/20209/30/20206/30/20203/31/2020
Market Cap (intraday) 5
8.71B9.19B8.96B8.98B11.37B8.03B
Enterprise Value 3
8.27B8.80B8.53B8.54B11.10B7.86B
Trailing P/E
22.4823.3898.8144.7364.21221.92
Forward P/E 1
34.9732.5732.5721.9838.1731.15
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
8.659.099.009.4613.3710.51
Price/Book (mrq)
7.238.1611.1410.8116.2412.61
Enterprise Value/Revenue 3
7.9137.2034.3933.0236.7033.14
Enterprise Value/EBITDA 7
61.25243.81164.90-183.98118.57159.69

Trading Information

Stock Price History

Beta (5Y Monthly) 0.77
52-Week Change 3-23.96%
S&P500 52-Week Change 341.30%
52 Week High 3136.26
52 Week Low 386.02
50-Day Moving Average 394.68
200-Day Moving Average 399.34

Share Statistics

Avg Vol (3 month) 31.17M
Avg Vol (10 day) 3792.68k
Shares Outstanding 594.55M
Implied Shares Outstanding 6N/A
Float 93.16M
% Held by Insiders 11.15%
% Held by Institutions 1101.75%
Shares Short (Apr 29, 2021) 46.02M
Short Ratio (Apr 29, 2021) 47.9
Short % of Float (Apr 29, 2021) 46.46%
Short % of Shares Outstanding (Apr 29, 2021) 46.37%
Shares Short (prior month Mar 30, 2021) 47M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Dec 28, 1995
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 38.45%
Operating Margin (ttm)28.71%

Management Effectiveness

Return on Assets (ttm)11.69%
Return on Equity (ttm)42.19%

Income Statement

Revenue (ttm)1.05B
Revenue Per Share (ttm)11.18
Quarterly Revenue Growth (yoy)-0.20%
Gross Profit (ttm)760.8M
EBITDA 309.1M
Net Income Avi to Common (ttm)402M
Diluted EPS (ttm)4.09
Quarterly Earnings Growth (yoy)-14.20%

Balance Sheet

Total Cash (mrq)873.7M
Total Cash Per Share (mrq)9.24
Total Debt (mrq)441.7M
Total Debt/Equity (mrq)36.64
Current Ratio (mrq)5.71
Book Value Per Share (mrq)12.76

Cash Flow Statement

Operating Cash Flow (ttm)280.3M
Levered Free Cash Flow (ttm)324.59M